(2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide

C23H22ClF2N5O2S — CID 162533806

IUPAC(2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide
SMILESO=C(NC1CCC(F)(F)CC1)[C@H](c1cnccn1)N(C(=O)CCl)c1ccc(-c2cncs2)cc1
InChIInChI=1S/C23H22ClF2N5O2S/c24-11-20(32)31(17-3-1-15(2-4-17)19-13-28-14-34-19)21(18-12-27-9-10-29-18)22(33)30-16-5-7-23(25,26)8-6-16/h1-4,9-10,12-14,16,21H,5-8,11H2,(H,30,33)/t21-/m0/s1
InChIKeySDWKGTBSCHFORD-NRFANRHFSA-N
MW505.98 g/mol
LogP4.61
Rot. Bonds7

About (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide

(2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide (PubChem CID 162533806) has the molecular formula C23H22ClF2N5O2S and a molecular weight of 505.98 g/mol. Its IUPAC name is (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide.

Molecular Properties

Compound Name(2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide
PubChem CID162533806
Molecular FormulaC23H22ClF2N5O2S
Molecular Weight505.98 g/mol
Exact Mass505.12
IUPAC Name(2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide
SMILESO=C(NC1CCC(F)(F)CC1)[C@H](c1cnccn1)N(C(=O)CCl)c1ccc(-c2cncs2)cc1
InChIInChI=1S/C23H22ClF2N5O2S/c24-11-20(32)31(17-3-1-15(2-4-17)19-13-28-14-34-19)21(18-12-27-9-10-29-18)22(33)30-16-5-7-23(25,26)8-6-16/h1-4,9-10,12-14,16,21H,5-8,11H2,(H,30,33)/t21-/m0/s1
InChIKeySDWKGTBSCHFORD-NRFANRHFSA-N
XLogP4.61
TPSA88.08 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms34
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500505.98
LogP ≤ 54.61
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide?
The IUPAC name of (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide (CID 162533806) is (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide.
What is the SMILES notation for (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide?
The canonical SMILES for (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide is O=C(NC1CCC(F)(F)CC1)[C@H](c1cnccn1)N(C(=O)CCl)c1ccc(-c2cncs2)cc1.
What is the InChIKey of (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide?
The InChIKey is SDWKGTBSCHFORD-NRFANRHFSA-N. The full InChI is InChI=1S/C23H22ClF2N5O2S/c24-11-20(32)31(17-3-1-15(2-4-17)19-13-28-14-34-19)21(18-12-27-9-10-29-18)22(33)30-16-5-7-23(25,26)8-6-16/h1-4,9-10,12-14,16,21H,5-8,11H2,(H,30,33)/t21-/m0/s1.
What are the key properties of (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide?
(2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide has a molecular weight of 505.98 g/mol, XLogP of 4.61, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[N-(2-chloroacetyl)-4-(1,3-thiazol-5-yl)anilino]-N-(4,4-difluorocyclohexyl)-2-pyrazin-2-ylacetamide is sourced from PubChem (CID 162533806), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).